The authors' study aims to assess the association of early-phase tau-PET scans and F-fluorodeoxyglucose PET and their comparability in discriminating Alzheimer's disease patients and differentiating neurodegenerative patterns.
The authors' study aims to assess the association of early-phase tau-PET scans and F-fluorodeoxyglucose PET and their comparability in discriminating Alzheimer's disease patients and differentiating neurodegenerative patterns.